Victoria Shalhoub
Overview
Explore the profile of Victoria Shalhoub including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
1136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palladino A, Gee M, Shalhoub V, Kiaei D
Clin Chim Acta
. 2023 Jun;
548:117461.
PMID: 37390944
Background: The Enhanced Liver Fibrosis (ELF) Test comprises 3 direct serum markers of fibrosis-hyaluronic acid (HA), amino-terminal pro-peptide of type III procollagen (PIIINP), and tissue inhibitor of matrix metalloproteinase 1...
2.
Freeman J, Olson K, Conklin J, Shalhoub V, Johnson B, Bopp N, et al.
Clin Biochem
. 2021 Dec;
101:19-25.
PMID: 34933006
Background: Current serological methods for SARS-CoV-2 lack adequate standardization to a universal standard reference material. Standardization will allow comparison of results across various lab-developed and commercial assays and publications. SARS-CoV-2...
3.
Freeman J, Wilson K, Spears R, Shalhoub V, Sibley P
Clin Biochem
. 2015 Jun;
48(16-17):1097-104.
PMID: 26054580
Objectives: The ability of current immunoassays to accurately measure equimolar amounts of 25(OH)D2 and 25(OH)D3 has been recently questioned. This study determined serum 25(OH)D2, 25(OH)D3 and total serum 25(OH)D concentrations...
4.
Sun N, Guo Y, Liu W, Densmore M, Shalhoub V, Erben R, et al.
Sci Rep
. 2015 Feb;
5:8304.
PMID: 25665715
Chronic kidney disease (CKD) is a worldwide health problem. Serum levels of FGF23, a phosphaturic hormone, increase at the earliest stages of CKD, and have been found to be independently...
5.
Freeman J, Wilson K, Spears R, Shalhoub V, Sibley P
Int J Endocrinol
. 2014 Nov;
2014:653692.
PMID: 25388159
[This corrects the article DOI: 10.1155/2014/691679.].
6.
Donnelly J, Freeman J, Wilson K, Shalhoub V, Sibley P
Clin Chem Lab Med
. 2014 Oct;
53(5):e129-30.
PMID: 25332295
No abstract available.
7.
Freeman J, Wilson K, Spears R, Shalhoub V, Sibley P
Int J Endocrinol
. 2014 Jul;
2014:691679.
PMID: 25045351
Vitamin D status in different populations relies on accurate measurement of total serum 25-hydroxyvitamin D [25(OH)D] concentrations [i.e., 25(OH)D3 and 25(OH)D2]. This study evaluated agreement between the ADVIA Centaur Vitamin...
8.
Andrukhova O, Slavic S, Smorodchenko A, Zeitz U, Shalhoub V, Lanske B, et al.
EMBO Mol Med
. 2014 May;
6(6):744-59.
PMID: 24797667
Fibroblast growth factor-23 (FGF23) is a bone-derived hormone regulating renal phosphate reabsorption and vitamin D synthesis in renal proximal tubules. Here, we show that FGF23 directly regulates the membrane abundance...
9.
Andrukhova O, Smorodchenko A, Egerbacher M, Streicher C, Zeitz U, Goetz R, et al.
EMBO J
. 2014 Jan;
33(3):229-46.
PMID: 24434184
αKlotho is thought to activate the epithelial calcium channel Transient Receptor Potential Vanilloid-5 (TRPV5) in distal renal tubules through its putative glucuronidase/sialidase activity, thereby preventing renal calcium loss. However, αKlotho...
10.
Shalhoub V, Shatzen E, Ward S, Davis J, Stevens J, Bi V, et al.
J Clin Invest
. 2012 Jun;
122(7):2543-53.
PMID: 22728934
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is associated with secondary hyperparathyroidism (HPT) and serum elevations in the phosphaturic hormone FGF23, which may be maladaptive and lead to increased morbidity...